Tramadol with or without paracetamol (acetaminophen) for cancer pain

The Cochrane Database of Systematic Reviews
Philip J WiffenR Andrew Moore

Abstract

Tramadol is an opioid analgesic licensed for use in moderate to severe pain. It is considered as a low risk for abuse, so control regulations are not as stringent as for 'strong' opioids such as morphine. It has a potential role as a step 2 option of the World Health Organization (WHO) analgesic ladder. To assess the benefits and adverse effects of tramadol with or without paracetamol (acetaminophen) for cancer-related pain. We searched the following databases using a wide range of search terms: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and LILACS. We also searched three clinical trials registry databases. The date of the last search was 2 November 2016. We selected studies that were randomised, with placebo or active controls, or both, and included a minimum of 10 participants per treatment arm. We were interested particularly in blinded studies, but also included open studies.We excluded non-randomised studies, studies of experimental pain, case reports, and clinical observations. Two review authors independently extracted data using a standard form and checked for agreement before entry into Review Manager 5. We included information about the number of participants treated and demographic...Continue Reading

References

Aug 1, 1987·Annals of Internal Medicine·K A L'AbbéK O'Rourke
Feb 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C H Wilder-SmithH J Senn
Feb 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Q LiP Fitzgerald-Bocarsly
Nov 20, 1998·BMJ : British Medical Journal·J Hardy
May 21, 1999·Lancet·R K Portenoy, P Lesage
Aug 10, 2000·Drugs·L J Scott, C M Perry
Apr 9, 2001·The Journal of Continuing Education in the Health Professions·G MowattP E Mazmanian
Nov 30, 2002·Journal of Pain and Symptom Management·Leonidas Goudas, Daniel B Carr
Jun 17, 2004·Palliative Medicine·Colette Reid, Andrew Davies
Oct 29, 2004·Clinical Pharmacokinetics·Stefan Grond, Armin Sablotzki
Jan 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sebastiano MercadanteCarla Ripamonti
Mar 10, 2005·British Journal of Cancer·C ValeUNKNOWN UK Coordinating Committee for Cancer Research National Register of Cancer
Jun 18, 2005·Clinical Pharmacology and Therapeutics·Rasmus Steen PedersenKim Brosen
Dec 6, 2005·Paediatric Anaesthesia·Pervin Bozkurt
Jul 21, 2006·The Cochrane Database of Systematic Reviews·J HollingsheadD R Cornblath
Jul 21, 2006·The Cochrane Database of Systematic Reviews·M S CepedaL Valencia
Dec 21, 2006·Clinical Drug Investigation·Daniel Arbaiza, Oscar Vidal
Feb 15, 2007·Journal of Palliative Medicine·Rene Fernando RodriguezMario Fernando Rodriguez
Jun 16, 2007·Molecular Diagnosis & Therapy·Siew Hua GanWan Zulmi
Nov 8, 2007·Pain Practice : the Official Journal of World Institute of Pain·Franco MarinangeliGiustino Varrassi
Dec 7, 2007·The Journal of Pain : Official Journal of the American Pain Society·Robert H DworkinStojan Zavisic
Feb 8, 2008·Journal of Computer-aided Molecular Design·Robert D Clark, Daniel J Webster-Clark
Jan 31, 2009·Drugs of Today·Roy R Reeves, Randy S Burke
Feb 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H BreivikL Dow
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Jul 20, 2010·BMJ : British Medical Journal·Eveline NüeschPeter Jüni
Oct 16, 2010·International Journal of Clinical Practice·W Leppert, M Majkowicz
Jun 4, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·K Forbes
Aug 2, 2011·Journal of Clinical Epidemiology·Gordon H GuyattUNKNOWN GRADE Working Group
Aug 27, 2011·The American Journal of Hospice & Palliative Care·Di DengYun Feng Zhou
May 23, 2012·Journal of Clinical Epidemiology·Gordon H GuyattHolger J Schünemann
Dec 12, 2012·International Journal of Cardiology·Zaina AlBalawiJørn Wetterslev
Apr 26, 2013·BMJ : British Medical Journal·Agnes DechartresPhilippe Ravaud
Jul 13, 2013·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Lukas RadbruchPeter Cremer-Schaeffer
Jul 25, 2013·The Cochrane Database of Systematic Reviews·Philip J WiffenR Andrew Moore

❮ Previous
Next ❯

Citations

Jul 13, 2017·The Cochrane Database of Systematic Reviews·Sheena DerryBee Wee
May 20, 2020·The Journal of Pharmacy and Pharmacology·Mi JinChenxiang Wang
Feb 21, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F V EstévezUNKNOWN Grupo de trabajo de dolor oncológico of the SED (Sociedad Española de Dolor)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Cochrane Database of Systematic Reviews
Sheena DerryR Andrew Moore
The Cochrane Database of Systematic Reviews
Sheena DerryR Andrew Moore
© 2022 Meta ULC. All rights reserved